ACTIVE

MEDPACE LABORATORIES

Export PDF

Financial year 2025 · closed on 31/12/2025

Net result

1,4 M €

-2.0% YoY

Revenue

58,2 M €

+1.8% YoY

Equity

17,1 M €

+9.2% YoY

Workforce

156,5 ETP

-2.4% YoY

What does MEDPACE LABORATORIES do?

MEDPACE LABORATORIES is a Private limited company incorporated in 2006. Its registered office is in Leuven. It employs on average 156,5 ETP workers (FTE).

Legal situation

● Normal situation

BCE/KBO no. / VAT

BE 0879.502.859

Incorporation

20/02/2006

Legal form

Private limited company

Registered office

Technologielaan 19
3001 Leuven · FlandreSee on map

Contributed capital

8 200 000,00 €

Latest accounts

31/12/2025

Average workforce

156,5 ETP

Joint committees (2)

330
33004

Signals

ProfitableSolid equityLow riskPositive cashflowPositive EBITDAHealthy social debtsHigh revenue

View the BCE/KBO Public Search record →

Health score

Available with a Rovalta subscriptionTry for 7 days

Recommended credit limit

✦ Verdict · Analyst summary

Financials

Trend over 17 financial years

	2025		2024		2023		2022		2021		2017		2016		2015		2014		2013		2012		2011		2010		2009		2008		2007		2006
Income statement
Revenue	58,2 M €	+1.8%	57,1 M €	-0.8%	57,6 M €	+18.2%	48,7 M €	+35.4%	36 M €	+139%	15,1 M €	+17.2%	12,8 M €	+24.4%	10,3 M €	+26.6%	8,2 M €	+38.3%	5,9 M €	+11.1%	5,3 M €	-35.2%	8,2 M €	-37.3%	13,1 M €	-6.9%	14 M €		–		–		–
EBITDA	3,1 M €	-8.4%	3,4 M €	+4.9%	3,2 M €	+30.5%	2,5 M €	+35.9%	1,8 M €	+173%	667,6 k €	+6.5%	627 k €	+23.9%	506,1 k €	+5.8%	478,1 k €	+27.9%	373,9 k €	-12.5%	427,5 k €	-80.3%	2,2 M €	-39.7%	3,6 M €	+122%	1,6 M €	+932%	157,6 k €	+110%	-1,5 M €	-911%	-152,1 k €
Operating result	2 M €	+3.6%	1,9 M €	-1.1%	2 M €	+53.5%	1,3 M €	+51.5%	846,4 k €	+92.9%	438,8 k €	+8.6%	404 k €	+12.4%	359,3 k €	+11.4%	322,6 k €	+50.7%	214,1 k €	-23.5%	279,8 k €	-85.9%	2 M €	-39.4%	3,3 M €	+150%	1,3 M €	+930%	-157,5 k €	+91.2%	-1,8 M €	-394%	-360,2 k €
Net result	1,4 M €	-2.0%	1,5 M €	-9.9%	1,6 M €	+66.8%	975 k €	+50.1%	649,7 k €	+162%	247,6 k €	+9.0%	227,2 k €	-2.9%	234,1 k €	-37.2%	372,6 k €	+17.8%	316,1 k €	-19.9%	394,5 k €	-72.1%	1,4 M €	-47.9%	2,7 M €	+176%	982,2 k €	+370%	-363,4 k €	+80.9%	-1,9 M €	-366%	-409,3 k €
Balance sheet
Equity	17,1 M €	+9.2%	15,7 M €	+10.3%	14,2 M €	+69.6%	8,4 M €	+13.2%	7,4 M €	+44.5%	5,1 M €	+5.1%	4,9 M €	+4.9%	4,6 M €	-38.2%	7,5 M €	+5.2%	7,1 M €	+4.6%	6,8 M €	+6.1%	6,4 M €	+28.2%	5 M €	+118%	2,3 M €	+74.4%	1,3 M €	+619%	183,6 k €	-91.2%	2,1 M €
Total assets	25,6 M €	-3.9%	26,6 M €	-8.5%	29,1 M €	+48.3%	19,6 M €	+6.2%	18,5 M €	+121%	8,4 M €	+36.7%	6,1 M €	+3.5%	5,9 M €	-35.6%	9,2 M €	+3.9%	8,8 M €	+3.6%	8,5 M €	-3.1%	8,8 M €	+8.2%	8,1 M €	+39.2%	5,8 M €	-1.3%	5,9 M €	+23.2%	4,8 M €	+8.1%	4,4 M €
Cash	218,1 k €	-85.2%	1,5 M €	-70.7%	5 M €	+4553%	108,5 k €	-93.5%	1,7 M €	+1667%	94 k €	-93.1%	1,4 M €	+400%	273,8 k €	+78.0%	153,8 k €	+140%	64,1 k €	+7.9%	59,4 k €	-54.9%	131,8 k €	-86.0%	941,1 k €	+83.0%	514,2 k €	+721%	62,7 k €	-89.5%	598,9 k €	+57.8%	379,5 k €
Debts	8,5 M €	-22.0%	10,8 M €	-27.1%	14,9 M €	+32.4%	11,2 M €	+1.5%	11,1 M €	+241%	3,2 M €	+160%	1,2 M €	-0.3%	1,3 M €	-24.7%	1,7 M €	-1.2%	1,7 M €	-0.9%	1,7 M €	-28.6%	2,4 M €	-23.9%	3,1 M €	-11.8%	3,5 M €	-23.0%	4,6 M €	-0.5%	4,6 M €	+96.1%	2,4 M €
Other
Workforce	156,5 ETP	-2.4%	160,4 ETP	-0.3%	160,9 ETP	+17.5%	136,9 ETP	+23.0%	111,3 ETP	+88.6%	59,0 ETP	+8.9%	54,2 ETP	+27.8%	42,4 ETP	+13.4%	37,4 ETP	+28.1%	29,2 ETP	+5.0%	27,8 ETP	-9.2%	30,6 ETP	-24.8%	40,7 ETP	+15.6%	35,2 ETP	+65.3%	21,3 ETP	+43.9%	14,8 ETP	+55.8%	9,5 ETP

Estimate

Indicative valuation

As an indication, this company is worth

between 25 M€ and 50 M€

See the valuation

Governance

Board of directors

Seen on filing of 31/12/2025 · 5 active · 6 ended

Active mandates

Brad William Hansman

Director · since 20 mai 2026

Active

John Thomas Wynne II

Director · since 20 mai 2026

Active

Kevin Michael Brady

Director · since 20 mai 2026

Active

Jesse Jacob Geiger

Director · since 01 février 2021 · until 19 mai 2026

Active

Stephen Paul Ewald

Director · since 01 février 2021

Active

Ended mandates

Jesse Jacob Geiger

Director · since 01 février 2021

Ended

August Troendle

Director · until 01 février 2021

Ended

August Troendle

Director

Ended

August Troendle

Manager

Ended

Annual accounts

Full financial information

	2025	2024	2023	2022	2021	2020
Type of account	Full model	Full model	Full model	Full model	Full model	Full model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	31/07/2026	09/09/2025	30/07/2024	19/07/2023	30/08/2022	28/07/2021
General meeting	28/07/2026	27/08/2025	30/07/2024	17/07/2023	29/08/2022	23/07/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Ratios

Financial ratios

Looking for more information about this company?

Try for 7 days

Filings

Annual accounts filings

21 filings with the NBB

Model	Closing	General meeting	Filed	Language	Document
Full model	31/12/2025	28/07/2026	31/07/2026	Dutch	PDF
Full model	31/12/2024	27/08/2025	09/09/2025	Dutch	PDF
Full model	31/12/2023	30/07/2024	30/07/2024	Dutch	PDF
Full model	31/12/2022	17/07/2023	19/07/2023	Dutch	PDF
Full model	31/12/2021	29/08/2022	30/08/2022	Dutch	PDF
Full model	31/12/2020	23/07/2021	28/07/2021	Dutch	PDF
Full model	31/12/2019	30/06/2020	02/07/2020	Dutch	PDF
Full model	31/12/2018	28/06/2019	31/07/2019	Dutch	PDF
Full model	31/12/2017	15/08/2018	31/08/2018	Dutch	PDF
Full model	31/12/2016	28/08/2017	31/08/2017	Dutch	PDF
Full model	31/12/2015	27/06/2016	28/07/2016	Dutch	PDF
Full model	31/12/2014	27/06/2015	30/06/2015	Dutch	PDF
Full model	31/12/2013	27/06/2014	16/07/2014	Dutch	PDF
Full modelCorrection	31/12/2012	28/06/2013	30/10/2013	Dutch	PDF
Full model	31/12/2012	28/06/2013	25/07/2013	Dutch	PDF
Full model	31/12/2011	29/06/2012	30/07/2012	Dutch	PDF
Full model	31/12/2010	30/06/2011	22/07/2011	Dutch	PDF
Full model	31/12/2009	30/06/2010	31/08/2010	Dutch	PDF
Abridged model	31/12/2008	26/04/2009	28/08/2009	Dutch	PDF
Abridged model	31/12/2007	26/04/2008	26/08/2008	Dutch	PDF
Abridged model	31/12/2006	16/04/2007	30/08/2007	Dutch	PDF

Estimate

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 25 M€ and 50 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Governance

Board of directors

Seen on filing of 31/12/2025 · 5 active · 6 ended

Active mandates

Brad William Hansman

Director · since 20 mai 2026

Active

John Thomas Wynne II

Director · since 20 mai 2026

Active

Kevin Michael Brady

Director · since 20 mai 2026

Active

Jesse Jacob Geiger

Director · since 01 février 2021 · until 19 mai 2026

Active

Stephen Paul Ewald

Director · since 01 février 2021

Active

Ended mandates

Jesse Jacob Geiger

Director · since 01 février 2021

Ended

August Troendle

Director · until 01 février 2021

Ended

August Troendle

Director

Ended

August Troendle

Manager

Ended

Shareholders

Ownership and network

Looking for more information about this company?

Try for 7 days

Belgian Official Gazette

Belgian Official Gazette publications

Mandates22/05/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates09/01/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates16/01/2025
ONTSLAGEN - BENOEMINGEN
PDF
Other28/12/2023
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Other27/02/2023
DIVERSEN
PDF
Other20/05/2022
DIVERSEN
PDF
Other27/12/2021
DIVERSEN
PDF
Other02/04/2021
DIVERSEN
PDF

Source: Belgian Official Gazette

Competition

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

2025
Annual accounts 20251,4 M €↓
2024
Annual accounts 20241,5 M €↓
2023
Annual accounts 20231,6 M €↑
2022
Annual accounts 2022975 k €↑
2021
Annual accounts 2021649,7 k €↑
2017
Annual accounts 2017247,6 k €↑
2016
Annual accounts 2016227,2 k €↓
2015
Annual accounts 2015234,1 k €↓
2014
Annual accounts 2014372,6 k €↑
2013
Annual accounts 2013316,1 k €↓
2012
Annual accounts 2012394,5 k €↓
2011
Annual accounts 20111,4 M €↓
2010
Annual accounts 20102,7 M €↑
2009
Annual accounts 2009982,2 k €↑
2008
Annual accounts 2008-363,4 k €↑
2007
Annual accounts 2007-1,9 M €↓
2006
Annual accounts 2006-409,3 k €
20/02/2006
IncorporationPrivate limited company

10/15	1 240 000	1 180 000	1 050 000
70	8 630 000	8 120 000	7 940 000
9904	412 000	388 000	301 000
17/49	2 970 000	3 140 000	3 380 000
9087	24,3	23,1	21,8

MEDPACE LABORATORIES

Overview

What does MEDPACE LABORATORIES do?

Trend over 17 financial years

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline